Mercer WE - Search Results

1

Induction of WAF1/CIP1 by a p53-independent pathway.

Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Michieli P, et al. Among authors: mercer we. Cancer Res. 1994 Jul 1;54(13):3391-5. Cancer Res. 1994. PMID: 8012956

2

The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.

Fiscella M, Zambrano N, Ullrich SJ, Unger T, Lin D, Cho B, Mercer WE, Anderson CW, Appella E. Fiscella M, et al. Among authors: mercer we. Oncogene. 1994 Nov;9(11):3249-57. Oncogene. 1994. PMID: 7936649

3

Constitutive expression of B-myb can bypass p53-induced Waf1/Cip1-mediated G1 arrest.

Lin D, Fiscella M, O'Connor PM, Jackman J, Chen M, Luo LL, Sala A, Travali S, Appella E, Mercer WE. Lin D, et al. Among authors: mercer we. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10079-83. doi: 10.1073/pnas.91.21.10079. Proc Natl Acad Sci U S A. 1994. PMID: 7937841 Free PMC article.

4

Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase.

Lin D, Shields MT, Ullrich SJ, Appella E, Mercer WE. Lin D, et al. Among authors: mercer we. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9210-4. doi: 10.1073/pnas.89.19.9210. Proc Natl Acad Sci U S A. 1992. PMID: 1409626 Free PMC article.

5

WAF1, a potential mediator of p53 tumor suppression.

el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. el-Deiry WS, et al. Among authors: mercer we. Cell. 1993 Nov 19;75(4):817-25. doi: 10.1016/0092-8674(93)90500-p. Cell. 1993. PMID: 8242752 Free article.

6

Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.

Fiscella M, Ullrich SJ, Zambrano N, Shields MT, Lin D, Lees-Miller SP, Anderson CW, Mercer WE, Appella E. Fiscella M, et al. Among authors: mercer we. Oncogene. 1993 Jun;8(6):1519-28. Oncogene. 1993. PMID: 8502477

7

p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.

Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, Deisseroth AB, Mercer WE. Zhang W, et al. Among authors: mercer we. Cancer Res. 1995 Feb 1;55(3):668-74. Cancer Res. 1995. PMID: 7834638

8

Cell cycle effects of microinjected antisense oligodeoxynucleotides to p34cdc2 kinase.

Mercer WE, Ullrich SJ, Shields MT, Lin D, Alder H. Mercer WE, et al. Ann N Y Acad Sci. 1992 Oct 28;660:209-18. doi: 10.1111/j.1749-6632.1992.tb21073.x. Ann N Y Acad Sci. 1992. PMID: 1340123

9

Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.

Mercer WE, Shields MT, Lin D, Appella E, Ullrich SJ. Mercer WE, et al. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1958-62. doi: 10.1073/pnas.88.5.1958. Proc Natl Acad Sci U S A. 1991. PMID: 1705714 Free PMC article.

10

Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells.

Ullrich SJ, Mercer WE, Appella E. Ullrich SJ, et al. Among authors: mercer we. Oncogene. 1992 Aug;7(8):1635-43. Oncogene. 1992. PMID: 1630823

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters